Erratum: Skin substitutes and wound healing (Skin Pharmacol Physiol (2009) 22: 2 (94-102) DOI: 10.1159/000178868);Skin substitutes and wound healing

Skin Pharmacology and Physiology

Volumn 22, Issue 2, 2009, Pages 94-102

  Auger, F A ^a   Lacroix, D ^a   Germain, L ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Burns; Chronic wounds; Regenerative medicine; Skin substitutes; Tissue engineering

Indexed keywords

RECOMBINANT GROWTH FACTOR;

BURN PATIENT; CELL THERAPY; CHRONIC DISEASE; CHRONIC WOUND; HUMAN; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN FUNCTION; SURVIVAL; TISSUE REGENERATION; WOUND; WOUND HEALING;

EID: 59649089772     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000178868     Document Type: Erratum

References (33)

1. Garner JP, Brown R: Recent advances in topical agents for prehospital haemostasis. Trauma 2002;4:203-209.
2. Damour O, Gueugniaud PY, Berthin-Maghit M, Rousselle P, Berthod F, Sahuc F, Collombel C: A dermal substrate made of collagen-GAG-chitosan for deep burn coverage: first clinical uses. Clin Mater 1994;15:273-276.
3. Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
4. Spiekstra SW, Breetveld M, Rustemeyer T, Scheper RJ, Gibbs S: Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes. Wound Repair Regen 2007;15:708-717.
5. Laplante AF, Germain L, Auger FA, Moulin V: Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. FASEB J 2001;15:2377-2389.
6. Larouche D, Tong X, Fradette J, Coulombe PA, Germain L: Vibrissa hair bulge houses two populations of skin epithelial stem cells distinct by their keratin profile. FASEB J 2008;22:1404-1415.
7. Pellegrini G, Ranno R, Stracuzzi G, Bondanza S, Guerra L, Zambruno G, Micali G, De Luca M: The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 1999;68:868-879.
8. Sawicki G, Marcoux Y, Sarkhosh K, Tredget EE, Ghahary A: Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem 2005;269:209-216.
9. Mitrani E, Nadel G, Hasson E, Harari E, Shimoni Y: Epithelial-mesenchymal interactions allow for epidermal cells to display an in vivo-like phenotype in vitro. Differentiation 2005;73:79-87.
10. Dudas M, Wysocki A, Gelpi B, Tuan TL: Memory encoded throughout our bodies: Molecular and cellular basis of tissue regeneration. Pediatr Res 2008;63:502-512.
11. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA: Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221.
12. Woo K, Ayello EA, Sibbald RG: The edge effect: current therapeutic options to advance the wound edge. Adv Skin Wound Care 2007;20:99-117; quiz 118-119.
13. Velazquez OC, Snyder R, Liu ZJ, Fairman RM, Herlyn M: Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks. FASEB J 2002;16:1316-1318.
14. Johnstone CC, Farley A: The physiological basics of wound healing. Nurs Stand 2005;19:59-65; quiz 66.
15. Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE, Schwartz SI: Schwartz's Principles of Surgery, ed 8. New York, McGraw-Hill Companies Inc., 2005.
16. Yannas IV: Similarities and differences between induced organ regeneration in adults and early foetal regeneration. J R Soc Interface 2005;2:403-417.
17. Middelkoop E, van den Bogaerdt A, van Zuijlen P, Lamme E, Ulrich M: Living Skin Equivalents; Fibroblasts. European Tissue Repair Society Bulletin. Tissue Engineering I. http://www.etrs.org/bulletin12-1/section14.php.
18. MacNeil S: Progress and opportunities for tissue-engineered skin. Nature 2007;445:874-880.
19. Ehrenreich M, Ruszczak Z: Update on tissue-engineered biological dressings. Tissue Eng 2006;12:2407-2424.
20. Shores JT, Gabriel A, Gupta S: Skin substitutes and alternatives: a review. Adv Skin Wound Care 2007;20:493-508; quiz 509-510.
21. Ho C, Tran K, Hux M, Sibblad G, Campbell K: Artificial Skin Grafts in Chronic Wound Care: A Meta-Analysis of Clinical Efficacy and a Review of Cost-Effectiveness. 52. Ottawa, Canadian Coordinating Office for Health Technology Assessment, 2005.
22. Yoshida Y, Hachiya A, Sriwiriyanont P, Ohuchi A, Kitahara T, Takema Y, Visscher MO, Boissy RE: Functional analysis of keratinocytes in skin color using a human skin substitute model composed of cells derived from different skin pigmentation types. FASEB J 2007;21:2829-2839.
23. Caissie R, Gingras M, Champigny MF, Berthod F: In vivo enhancement of sensory perception recovery in a tissue-engineered skin enriched with laminin. Biomaterials 2006;27:2988-2993.
24. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA: Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 2005;5:1002-1010.
25. Brewster L, Brey EM, Addis M, Xue L, Husak V, Ellinger J, Haudenschild CC, Greisler HP: Improving endothelial healing with novel chimeric mitogens. Am J Surg 2006;192:589-593.
26. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E: Defining the epithelial stem cell niche in skin. Science 2004;303:359-363.
27. Michel M, Torok N, Godbout MJ, Lussier M, Gaudreau P, Royal A, Germain L: Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 1996;109:1017-1028.
28. Larouche D, Hayward C, Cuffley K, Germain L: Keratin 19 as a stem cell marker in vivo and in vitro. Methods Mol Biol 2005;289:103-110.
29. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin, II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
30. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 2007;448:313-317.
31. Akasaka Y, Ono I, Tominaga A, Ishikawa Y, Ito K, Suzuki T, Imaizumi R, Ishiguro S, Jimbow K, Ishii T: Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen 2007;15:378-389.
32. Ferguson MW, O'Kane S: Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004;359:839-850.
33. Fujimori Y, Ueda K, Fumimoto H, Kubo K, Kuroyanagi Y: Skin regeneration for children with burn scar contracture using autologous cultured dermal substitutes and superthin auto-skin grafts: preliminary clinical study. Ann Plast Surg 2006;57:408-414.